What Causes Myasthenia Gravis and Why Does the Thymus Matter?

The central puzzle is that an illness driven by the immune system can feel as though it arrived without warning or family precedent. That is not a contradiction. The evidence describes a chain rather than one culprit: susceptibility, a breakdown in immune tolerance, and antibodies that interfere with neuromuscular transmission. This distinction matters because it removes a common but unhelpful conclusion: a newly diagnosed person did not cause MG by being stressed, getting an ordinary infection, or failing to notice something sooner.

What causes myasthenia gravis if no one in my family has it?

MG can develop with no known family history because it is an acquired autoimmune disease, not a condition that requires a parent to pass down one decisive faulty gene. According to the National Institute of Neurological Disorders and Stroke, antibodies can block, alter, or destroy acetylcholine receptors at the neuromuscular junction, the point where a nerve signals a muscle to contract. Antibodies to muscle-specific kinase, known as MuSK, can also impair this transmission.

That mechanism explains weakness; it does not fully explain why a particular immune system begins producing those antibodies. The 2021 Journal of Clinical Medicine review separates predisposition from established cause: genetic background and environmental factors influence autoimmune MG, but the environmental factors are not fully understood. In plain terms, medicine has identified important pieces of the machinery without identifying one universal starting event.

The thymus is one of those important pieces. This organ helps develop T cells, immune cells involved in recognizing threats and maintaining tolerance to the body’s own tissues. NINDS explains that many adults with MG have a persistently enlarged thymus or clusters of immune cells there. The proposed consequence is precise: the thymus may give developing immune cells incorrect instructions, helping set up an attack on acetylcholine receptors.

Cause, trigger, and crisis precipitant are therefore different categories. A trigger can reveal or worsen a process already underway; it does not prove that it created the disease from nothing.

Is myasthenia gravis genetic or inherited?

MG has genetic susceptibility, but it is not generally inherited as a straightforward single-gene condition. NINDS states plainly that “Myasthenia gravis is not inherited or contagious,” while also acknowledging that it occasionally occurs in more than one family member. Those two facts fit together: relatives can share some background risk without MG following a predictable family pattern.

The 2024 genome-wide meta-analysis published in Nature Communications identified 12 independent genetic signals across 11 loci in its European-ancestry datasets. In the independent cohort, the study’s polygenic risk score explained 4.21% of phenotypic variation, according to the 2024 paper. That is the opposite of a genetic verdict: currently measured common variants account for only a limited share of observed risk.

The study also found different associated signals for early- and late-onset MG. This supports a useful conclusion: “MG” names a related group of autoimmune disorders, not a single biological script repeated unchanged in every patient. Family history may be part of the clinical picture, but it cannot by itself determine who will or will not develop autoimmune MG.

Can stress, an infection, or pregnancy trigger myasthenia gravis?

Stress, infection, and pregnancy can unmask or worsen MG, but none is established as the universal cause of MG. NINDS lists infection, stress, surgery, and adverse medication reactions as potential triggers of myasthenic crisis. NINDS also reports that approximately 15% to 20% of people with MG experience at least one crisis, and that up to 50% of those people cannot identify a trigger; these figures describe crisis triggers, not the original cause of MG.

The infection evidence deserves particular care because temporal sequence is not proof. A 2021 systematic review in Frontiers in Neurology reviewed 48 publications concerning infectious agents and MG onset and found generally weak overall evidence for causation. Its conclusion was direct: no infection has been proven to cause MG. An infection may be relevant in an individual timeline, but the research does not justify assigning it blame as the source of the disease.

Pregnancy is similarly a period of altered risk, not a moral or biological explanation for every diagnosis. The 2023 clinical review Pregnancy and Myasthenia Gravis states that MG is unmasked or worsened during pregnancy in approximately one-third of patients. In the same 2023 review, MG improved in about 30% to 40% of pregnancies, stayed unchanged in about 30% to 40%, and worsened in about 20% to 30%. The data had a different story from a simple rule: pregnancy can change disease activity in more than one direction.

Medication questions require the same discipline. The 2021 Frontiers in Neurology review identifies D-penicillamine as a prototypical medicine reported to induce new-onset MG and describes growing evidence for progressive MG associated with immune checkpoint inhibitor cancer treatments. This is not evidence that a medication caused every diagnosis that follows a prescription. It is evidence that medication history is relevant clinical information.